Vitamin D Effect on the Severity of Chronic Pelvic Pain in Patients with Ovarian Endometriosis Combined with Pelvic Inflammatory Diseases

Keywords: Ovarian endometriosis, Pelvic inflammatory disease, Pelvic pain syndrome, Vitamin D concentration


Numerous publications in recent years indicate the impact of vitamin D deficiency on the course and severity of a number of gynecological diseases, including endometrial disease. As this transmitter is associated with immune disorders, its involvement in local immunosuppression in the progression of the systemic inflammatory response in the case of endometrial disease is not excluded. Considering the pathogenetic links between vitamin D metabolism and the severity of pelvic pain, it became appropriate to study the relationship between this parameter and the intensity of pelvic pain in patients with ovarian endometriomas associated with chronic pelvic inflammatory diseases, which was the objective of this research. Materials and methods of research. The study included 90 patients with ovarian endometriosis aged 20 to 41 years. The main group consisted of 44 patients with endometrioma combined with pelvic inflammatory diseases; the comparison group consisted of 46 patients with isolated ovarian endometrioma. The control group included 30 relatively healthy women without gynecological and somatic pathology. At the initial stage, the level of 25-hydroxyvitamin-D3 (25 (OH) D) was determined in patients of the three groups by mass spectrometry using standard methods. Analysis and discussion of research results. Patients with ovarian endometrial cysts on the background of pelvic inflammatory disease were statistically significantly older compared with the group of isolated endometriomas; more than half of the observations were patients aged 36-40 years (p<0.05). Laparoscopic diagnostic and therapeutic techniques allowed to present objective signs of combination of ovarian endometrioma with manifestations of external genital endometriosis: severe manifestations of external genital endometriosis were diagnosed in 31.8% vs. 15.21% in the comparison group. Depending on the severity of the pain syndrome according to VAS, patients of the main group were stratified as follows: 22.7% noted pelvic pain of low intensity, 40.9% – moderate pain, 25.0% – severe pain; in the comparison group there were no manifestations of severe pelvic pain. The combination of pelvic inflammatory disease with ovarian endometriosis was accompanied by an increase in the share of vitamin D deficiency – in 38.64% and the share of severe pain – in 25.0%.

Conclusion. A significantly moderate inverse correlation was found between the verification of the manifestations of external genital endometriosis and the level of vitamin D in the blood serum. The obtained data dictated the need to assess the therapeutic potential of vitamin D in combination with nonsteroidal anti-inflammatory drugs to enhance the analgesic effect and reduce the drug load.

Author Biography

Ruslana Bihun, Ivano-Frankivsk National Medical University, Ukraine

Department of Obstetrics and Gynecology named after I.D. Lanovyi


Barsegyan LK, Orazov MR, Tokayeva ES. Predictors of bone metabolic disorders in women with endometriosis-related pelvic pain. Mosk khirurgich zhurn. 2016; 5(51):13-5 [in Russian].

Ciavattini A, Serri M, Delli Carpini G, Morini S, Clemente N. Ovarian endometriosis and vitamin D serum levels. Gynecol Endocrinol. 2017;33(2):164-167. Available from:

Denisova AS, Yarmolinskaya MI. Role of vitamin D in the pathogenesis of genital endometriosis. Zhurn akusherstva i zhenskikh bolezney. 2017;66(6):81-6 [in Russian]. Available from:

Dobrokhotova YuE, Kalimatova DM. The effect of vitamin D on endometriosis. Farmateca. 2018; 6: 39-47.

Available from:

Fang F, Ni K, Cai Y, Shang J, Zhang X, Xiong C. Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract. 2017; 26: 53-60. Available from:

Gysemans CA, Cardozo AK, Callewaert H, Giulietti A, Hulshagen L, Bouillon R, Eizirik DL, Mathieu C. 1.25-Dihy-droxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in non-obese diabetic mice. Endocrinology. 2014;146(4):1956-64. Available from:

Maltseva LI, Garifullova YuV, Yupatov EYu. Realities and perspectives of vitamin D use in maintaining female reproductive. Akusherstvo i ginekologiya. 2020;10:174-181 [in Russian]. Available from:

Orazov MR, Khamoshina MB, Orazmuradov AA, Kaigorodova LA, Marapov DI, Barsegvan LK. Vitamin D levels in women with endometriosis-associated pelvic pain. Zhurn Ginekologiya. Endokrinologiya. 2017; 9(138): 17-20 [in Russian].

Orazov MR, Radzinsky VE, Khamoshina MB, Nosenko EN, Dukhin AO, Tokaeva ES, Barsegyan LK, Shkrei II, Marapov DI, Simenel ES, Belov DA, Nizhnik AN. Vitamin D3 (cholecalciferol) and pelvic pain induced by ovarian endometriosis. Trudnyy patsiyent, 2018; 4(16): 34-39 [in Russian].

Qiu Y, Yuan S, Wang H. Vitamin D status in endometriosis: a systematic review and meta analysis. Arch. Gynecol. Obstet. 2020; 302(1): 141-52. Available from:

Original Research